Description
**MOTS-C Research Overview**
—
**1. What it does**
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-C) is a mitochondrial-derived peptide that regulates metabolic functions. It plays a critical role in promoting insulin sensitivity, regulating energy balance, and enhancing fat metabolism. MOTS-C acts at the cellular level to optimize mitochondrial function, improve glucose metabolism, and protect against metabolic stress.
—
**2. What are the main reported benefits**
– Improved insulin sensitivity and glucose metabolism
– Enhanced fat burning and weight management
– Increased endurance and physical performance
– Protection against diet-induced obesity and metabolic syndrome
– Support for mitochondrial health and cellular energy production
– Anti-aging and longevity benefits (under investigation)
– Protection against oxidative stress
—
**3. What are its normal applications**
– Research into metabolic disorders such as type 2 diabetes and obesity
– Studies on exercise performance and endurance enhancement
– Investigations into mitochondrial function and aging
– Experimental anti-aging and longevity research
—
**4. What are its common side effects**
MOTS-C has been well tolerated in animal studies. Potential mild side effects based on anecdotal reports include:
– Mild fatigue after injection
– Temporary headache
– Injection site irritation
Long-term human data is limited, so ongoing monitoring in research settings is recommended.
—
**5. What is the recommended administration or dosage**
– **Typical Dosage**: 5 mg to 15 mg per administration
– **Administration Route**: Subcutaneous injection
**Timing:**
– Commonly administered 1 to 3 times per week depending on the research protocol
**Preparation:**
– Supplied as a lyophilized powder and must be reconstituted with bacteriostatic water prior to administration.
*Note:* MOTS-C may be used cyclically in research to optimize mitochondrial health without promoting desensitization.
—
